Bioventus Inc. (BVS) has a MoatMap StockRank of 96/100 based on Quality (66/100), Value (54/100), and Momentum (70/100) factor scores. The current signal is STRONG BUY. Bioventus operates in the orthobiologics space but carries a historically weak balance sheet and low quality metrics. It lacks any structural alignment with our core macro themes and does not meet the Terry Smith quality threshold.
Bioventus Inc. is a global medical technology company focused on developing and commercializing orthobiologic solutions for musculoskeletal conditions, including bone healing, pain management, and surgical applications. Its competitive edge stems from a diversified portfolio of clinically-backed, often patented products that address significant unmet needs in orthopedics. The company serves a specialized market through strong relationships with healthcare professionals.
| Price | $9.06 |
| Market Cap | $601M |
| P/E (TTM) | 21.22 |
| P/E (Forward) | 9.60 |
| Price/Book | 3.11 |
| Return on Equity | 16.5% |
| Return on Invested Capital | 10.0% |
| Debt/Equity | 123.12 |
| Gross Margin | 68.7% |
| Operating Margin | 6.7% |
| Revenue Growth | 6.6% |
| Free Cash Flow | $63M |
Bioventus Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).